tiprankstipranks
Intellia Therapeutics (NTLA)
NASDAQ:NTLA
US Market

Intellia Therapeutics (NTLA) Technical Analysis

Compare
3,396 Followers

Technical Sentiment

Overall Consensus
Neutral
10Bullish
3Neutral
9Bearish
Technical Analysis Consensus
Sell
2Bullish
3Neutral
5Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Intellia Therapeutics’s (NTLA) Moving Averages Convergence Divergence (MACD) indicator is 0.03, suggesting Intellia Therapeutics is a Sell.
Intellia Therapeutics’s (NTLA) 20-Day exponential moving average is 10.68, while Intellia Therapeutics’s (NTLA) share price is $12.25, making it a Buy.
Intellia Therapeutics’s (NTLA) 50-Day exponential moving average is 11.65, while Intellia Therapeutics’s (NTLA) share price is $12.25, making it a Buy.

Intellia Therapeutics (NTLA) Pivot Points

Feb 21, 2025, 09:24 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
10.25
10.87
11.57
12.19
12.89
13.51
14.21
Fibonacci
10.87
11.37
11.68
12.19
12.69
13.00
13.51
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Intellia Therapeutics (NTLA) Moving Averages

Feb 21, 2025, 09:24 PM
Period
Simple
Exponential
MA5
11.28Buy
11.48Buy
MA10
10.46Buy
10.91Buy
MA20
10.40Buy
10.68Buy
MA50
11.36Buy
11.65Buy
MA100
14.10Sell
13.97Sell
MA200
18.84Sell
18.08Sell
Intellia Therapeutics’s (NTLA) 10-Day exponential moving average is 10.91, while Intellia Therapeutics’s (NTLA) share price is $12.25, making it a Buy.
Intellia Therapeutics’s (NTLA) 100-Day exponential moving average is 13.97, while Intellia Therapeutics’s (NTLA) share price is $12.25, making it a Sell.
Intellia Therapeutics’s (NTLA) stock price is $12.25 and Intellia Therapeutics’s (NTLA) 50-day simple moving average is 11.36, creating a Buy signal.
Intellia Therapeutics’s (NTLA) stock price is $12.25 and Intellia Therapeutics’s (NTLA) 100-day simple moving average is 14.10, creating a Sell signal.
Intellia Therapeutics’s (NTLA) stock price is $12.25 and Intellia Therapeutics’s (NTLA) 200-day simple moving average is 18.84, creating a Sell signal.

Intellia Therapeutics (NTLA) Technical Indicators

Feb 21, 2025, 09:24 PM
Name
Value
Implied Action
RSI (14)
62.59
Neutral
STOCH (9,6)
84.81
Sell
STOCHRSI (14)
84.81
Sell
MACD (12,26)
0.03
Sell
ADX (14)
20.91
Neutral
Williams %R
-15.21
Sell
CCI (14)
203.69
Sell
ATR (14)
0.81
-
Ultimate Oscillator
56.88
Neutral
ROC
16.56
Buy
Intellia Therapeutics’s (NTLA) Relative Strength Index (RSI) is 62.59, creating a Neutral signal.
Intellia Therapeutics’s (NTLA) Trend Strength Indicator (ADX) is 20.91, creating a Neutral signal.
Intellia Therapeutics’s (NTLA) Commodity Channel Index (CCI) is 203.69, creating a Sell signal.
Intellia Therapeutics’s (NTLA) Price Rate of Change (ROC) is 16.56, creating a Buy signal.

FAQ

Is NTLA a Buy, Hold, or Sell?
Based on NTLA’s technical indicators, NTLA is a Hold.
    What is NTLA’s RSI (14)?
    NTLA’s RSI (14) is 62.59, which suggests NTLA is a Neutral.
      What is NTLA’s MACD?
      NTLA’s MACD is 0.03, which suggests NTLA is a Sell.
        What is NTLA’s 5-day moving average?
        NTLA’s 5-day moving average is 11.28, which suggests NTLA is a Buy.
          What is NTLA’s 20-day moving average?
          NTLA 20-day moving average is 10.40, which suggests NTLA is a Buy.
            What is NTLA’s 50-day moving average?
            NTLA’s 50-day moving average is 11.36, which suggests NTLA is a Buy.
              What is NTLA’s 200-day moving average?
              NTLA’s 200-day moving average is 18.84, which suggests NTLA is a Sell.
                What is NTLA’s Williams % R (14)?
                NTLA’s Williams % R (14) is -15.21, which suggests NTLA is a Sell.
                  What is NTLA’s CCI (14)?
                  NTLA’s CCI (14) is 203.69, which suggests NTLA is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis